Lyell Immunopharma, Inc.
Ticker: 1806952
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q3 FY24 | Q2 FY24 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 0.00 | 0.00 | 0.00-100.0% | 0.02+100.0% | 0.01+0.0% | 0.01-66.7% | 0.03+200.0% | 0.01 |
| Total Income | 0.00 | 0.00 | 0.00-100.0% | 0.02+100.0% | 0.01+0.0% | 0.01-66.7% | 0.03+200.0% | 0.01 |
| EXPENSES | ||||||||
| Expenditure | 48.30+2.0% | 47.34+7.0% | 44.26+18.8% | 37.27-21.0% | 47.15-17.8% | 57.37+13.5% | 50.54-1.9% | 51.54 |
| PROFIT | ||||||||
| Net Profit | -45.53-1.7% | -44.76-85.3% | -24.15+37.8% | -38.85+9.0% | -42.68+18.2% | -52.20-17.1% | -44.58+2.7% | -45.81 |
| KEY METRICS | ||||||||
| OPM % | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| NPM % | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| EPS | -1.86+3.1% | -1.92-74.5% | -1.10+48.4% | -2.13+26.3% | -2.89-1505.6% | -0.18-5.9% | -0.17+5.6% | -0.18 |
Corporate Events
Board MeetingLYEL
202610Jun
Board Meeting
2026 Annual Meeting of Stockholders to elect Class II direct…
SEC Filing ↗